|
Volumn 14, Issue 11, 2013, Pages 951-954
|
Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
VACCINE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
BACTERIOLYSIS;
BACTERIOPHAGE;
CELL THERAPY;
GENE THERAPY;
HOST CELL;
HUMAN;
LAW;
MEDICAL PROCEDURES;
PHAGE THERAPY;
PRIORITY JOURNAL;
QUALITY CONTROL PROCEDURES;
RETICULOENDOTHELIAL SYSTEM;
SAFETY;
SOMATIC CELL;
TISSUE REGENERATION;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BACTERIOPHAGES;
EUROPE;
HUMANS;
LEGISLATION AS TOPIC;
SOCIAL CONTROL, FORMAL;
TREATMENT OUTCOME;
|
EID: 84887108922
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.1038/embor.2013.163 Document Type: Article |
Times cited : (32)
|
References (3)
|